13th C1-inhibitor deficiency and angioedema workshop-2023 : Edited by: Róbert Hohol; Lectored by: Henriette Farkas, Lilian Varga; Cover artwork: Gergely Hosszú. [PDF]
europepmc +1 more source
Angioedema as the first presentation of B-cell non-Hodgkin lymphoma – an unusual case with normal C1 esterase inhibitor level: a case report [PDF]
core +1 more source
Correction to "Identification of the Minimum Region of Bordetella pertussis Vag8 Required for Interaction With C1 Inhibitor". [PDF]
europepmc +1 more source
Lanadelumab for prevention of attacks of non-histaminergic normal C1 inhibitor angioedema: results from the randomized, double-blind CASPIAN Study and CASPIAN open-label extension. [PDF]
Riedl MA +9 more
europepmc +1 more source
Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency. [PDF]
Vincent D +10 more
europepmc +1 more source
Lanadelumab in a kidney transplant patient with hereditary angioedema due to C1-inhibitor deficiency and high cardiovascular risk - a case report. [PDF]
Gidaro A +8 more
europepmc +1 more source
Screening for type II hereditary angioedema-the "poor man's c1-inhibitor function". [PDF]
Jindal AK +7 more
europepmc +1 more source
Real-world outcomes of patients with hereditary angioedema with normal C1-inhibitor function and patients with idiopathic angioedema of unknown etiology in Canada. [PDF]
Adatia A +10 more
europepmc +1 more source
A real-world study of hereditary angioedema patients due to C1 inhibitor deficiency treated with danazol in the Brazilian Public Health System. [PDF]
Ritter AMV +6 more
europepmc +1 more source
Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: first evidence on prevalence and distribution from a large Italian cohort study. [PDF]
Triggianese P +21 more
europepmc +1 more source

